An investigation on behalf of investors of IMS Health Holdings Inc (NYSE:IMS) in connection with the proposed takeover was announced and NYSE:IMS stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 05/11/2016 -- The takeover of Danbury, CT based IMS Health Holdings Inc is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NYSE:IMS shares, concerning whether the takeover of IMS Health Holdings Inc by Quintiles Transnational Holdings is unfair.
Investors who purchased shares of IMS Health Holdings Inc (NYSE:IMS) and currently hold any of those NYSE:IMS shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain directors of IMS Health Holdings Inc breached their fiduciary duties owed to NYSE:IMS investors in connection with the proposed acquisition.
On May3, 2016, IMS Health Holdings Inc (NYSE:IMS) and Quintiles Transnational Holdings Inc. (NYSE:Q) announced that their respective boards of directors approved a merger agreement, pursuant to which the companies will be combined in an all-stock merger of equals transaction. Under the terms of the merger agreement, IMS Health Holdings Inc (NYSE:IMS) shareholders will receive a fixed exchange ratio of 0.384 shares of Quintiles common stock for each share of IMS Health common stock. Based on a closing price of $69.10 per NYSE:Q shares on May 2, 2016, shareholders of IMS Health Holdings Inc (NYSE:IMS) will receive a value of approximately $26.53 per NYSE:IMS share.
However, given that at least one analyst has set the high target price for NYSE:IMS shares at $32.00 per share, the investigation concerns whether the offer is unfair to NYSE:IMS stockholders. More specifically, the investigation concerns whether the IMS Health Holdings Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
On May 9, 2016, NYSE:IMS shares closed at $25.37 per share.
Those who are current investors in IMS Health Holdings Inc shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego